{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
CME Group, Inc.
CME Group, Inc. Experiences Revision in Its Stock Evaluation Amid Strong Market Performance
CME Group, Inc. has recently adjusted its valuation, with its current price reflecting a slight increase. The company has shown strong performance over the past year, significantly outperforming the S&P 500. Key metrics include a P/E ratio of 26, a price-to-book value of 3.48, and a notable dividend yield.
CME Group, Inc. Hits New 52-Week High at USD 329.16
CME Group, Inc. has achieved a new 52-week high, reflecting its strong performance in the capital markets industry with a notable one-year growth. The company, classified as large-cap, has a market capitalization of over USD 111 billion, a P/E ratio of 26.00, and a dividend yield of 1.62%.
CME Group, Inc. Hits New 52-Week High at $327.79
CME Group, Inc. achieved a new 52-week high of USD 327.79, showcasing a strong one-year performance of 64.46%. With a market capitalization of USD 111,097 million, the company has a P/E ratio of 26.00 and a dividend yield of 1.62%, indicating solid financial health in the capital markets industry.
CME Group Stock Hits Day Low of $306.37 Amid Price Pressure
CME Group, Inc. saw a decline in stock price today, contrasting with a gain in the S&P 500. Despite this, the company has shown resilience over the past month and year, outperforming the index. With strong financial metrics and high institutional holdings, CME Group remains a significant player in the capital markets industry.
CME Group Hits New 52-Week High at $322.29, Showcasing Strong Growth
CME Group, Inc. has achieved a new 52-week high, reflecting its strong performance in the capital markets industry with a notable one-year gain. The company, with a market capitalization of USD 111,097 million, showcases solid financial metrics, including a P/E ratio of 26.00 and a return on equity of 14.06%.
CME Group Hits Day High with Strong 3.55% Intraday Surge
CME Group, Inc. has shown strong performance in the capital markets, with significant increases over various time frames. The company maintains solid financial metrics, including a return on equity of 14.06% and a robust cash position of over USD 7 billion, reflecting investor confidence.
CME Group Hits Day High with Strong 3.32% Intraday Surge
CME Group, Inc. has demonstrated strong performance, achieving an intraday high and a notable annual return. The company reported impressive operating cash flow and a solid return on capital employed, alongside a substantial dividend per share. High institutional holdings further enhance its market position in the capital markets industry.
CME Group Hits New 52-Week High at $314.18, Showcasing Strong Growth
CME Group, Inc. has achieved a new 52-week high, reflecting its strong performance in the capital markets industry with a notable one-year return. The company, classified as large-cap, has a market capitalization of USD 111,097 million, a P/E ratio of 26.00, and a dividend yield of 1.62%.
Is CME Group, Inc. technically bullish or bearish?
As of August 12, 2025, CME Group's technical trend is mildly bullish, with mixed indicators across different time frames, while it has underperformed the S&P 500 recently but outperformed it year-to-date and over the past year.
Is CME Group, Inc. overvalued or undervalued?
As of June 30, 2025, CME Group, Inc. is fairly valued with a P/E ratio of 27, an EV to EBITDA of 22.04, and a Price to Book Value of 3.66, showing competitive positioning despite recent stock performance lagging behind the S&P 500 over longer periods.
Is CME Group, Inc. technically bullish or bearish?
As of June 27, 2025, CME Group, Inc. shows a bullish trend supported by strong monthly indicators, although short-term signals suggest some caution.
Is CME Group, Inc. overvalued or undervalued?
As of June 4, 2025, CME Group, Inc. is fairly valued with a P/E ratio of 27 and an EV to EBITDA of 22.04, outperforming the S&P 500 with a 1-year return of 40.20%, while its valuation is competitive compared to peers like Goldman Sachs and Morgan Stanley.
Is CME Group, Inc. technically bullish or bearish?
As of June 20, 2025, CME Group, Inc. shows a bullish trend supported by monthly indicators, though mixed signals from weekly indicators suggest some short-term weakness.
Who are in the management team of CME Group, Inc.?
As of March 2022, the management team of CME Group, Inc. includes Executive Chairman and CEO Terrence Duffy, Vice Chairman Charles Carey, Lead Independent Director Daniel Glickman, and several Independent Directors: Michael Spencer, Timothy Bitsberger, Dennis Chookaszian, and Elizabeth Cook. This team is responsible for the company's strategic direction and governance.
What does CME Group, Inc. do?
CME Group, Inc. operates in the capital markets, offering a variety of futures and options products across all asset classes. As of March 2025, it reported net sales of $1.642 billion and a net profit of $950 million, with a market cap of approximately $97.19 billion.
How big is CME Group, Inc.?
As of Jun 18, CME Group, Inc. has a market capitalization of $97.19 billion, with net sales of $6.28 billion and a net profit of $3.63 billion over the last four quarters. The company also reported total assets of $137.59 billion and shareholder's funds of $26.49 billion as of Dec 24.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
